3CJ

6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one

Created:2014-07-28
Last modified:  2014-08-20

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count21
Chiral Atom Count0
Bond Count21
Aromatic Bond Count0
2D diagram of 3CJ
Toggle HydrogenToggle Labels

Chemical Component Summary

Name6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one
Systematic Name (OpenEye OEToolkits)6-propyl-2-sulfanylidene-1H-pyrimidin-4-one
FormulaC7 H10 N2 O S
Molecular Weight170.232
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESACDLabs12.01S=C1NC(=CC(=O)N1)CCC
SMILESCACTVS3.385CCCC1=CC(=O)NC(=S)N1
SMILESOpenEye OEToolkits1.7.6CCCC1=CC(=O)NC(=S)N1
Canonical SMILESCACTVS3.385 CCCC1=CC(=O)NC(=S)N1
Canonical SMILESOpenEye OEToolkits1.7.6 CCCC1=CC(=O)NC(=S)N1
InChIInChI1.03 InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)
InChIKeyInChI1.03 KNAHARQHSZJURB-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB00550 
NamePropylthiouracil
Groups
  • investigational
  • approved
DescriptionA thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. (From Martindale, The Extra Pharmacopeoia, 30th ed, p534)
Synonyms
  • Propylthiouracil
  • 2-Thio-4-oxo-6-propyl-1,3-pyrimidine
  • Propylthiouracile
  • Propylthiouracilum
  • 2-Mercapto-6-propylpyrimid-4-one
Brand Names
  • Propyl-thyracil
  • Apo-propylthiouracil
  • Halycil
  • PMS-propylthiouracil
  • Propylthiouracil Tablets
IndicationUsed to manage hyperthyroidism which is due to an overactive thyroid gland (Grave's disease).
Categories
  • Agents Causing Muscle Toxicity
  • Antimetabolites
  • Antithyroid agents
  • Hormone Antagonists
  • Hormones, Hormone Substitutes, and Hormone Antagonists
ATC-CodeH03BA02
CAS number51-52-5

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Type I iodothyronine deiodinaseMGLPQPGLWLKRLWVLLEVAVHVVVGKVLLILFPDRVKRNILAMGEKTGM...unknowninhibitor
Thyroid peroxidaseMRALAVLSVTLVMACTEAFFPFISRGKELLWGKPEESRVSSVLEESKRLV...unknowninhibitor
MyeloperoxidaseMGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAA...unknowninhibitor
Dopamine beta-hydroxylaseMPALSRWASLPGPSMREAAFMYSTAVAIFLVILVAALQGSAPRESPLPYH...unknowninhibitor
Cytochrome P450 1A1MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...unknowninducer
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1518
PubChem 5281043, 657298, 4950
ChEMBL CHEMBL1518
ChEBI CHEBI:8502
CCDC/CSD UXIXUV, CALFUS, QUHQIV, UXIXUV01, CALGAZ, QUHQIV01, BUWYOH, OKEYOV, OKEZAI, OKEYUB, OKEYIP
COD 2018297, 2018299